Playback speed
×
Share post
Share post at current time
0:00
/
0:00
Transcript

LTR Weekly Digest #40 - 15th June, 2024

Catch up on this week's articles - bonus webinar recording, QMSR tip, software risk analysis, 5 top LTR podcasts and a quick tip to understand patient perspective.

Dear colleagues, hello! 👋

A special welcome to the 80 new members who joined our Let’s Talk Risk! community in the month of June so far! Feel free to browse past articles in the archive section of the Let’s Talk Risk! website, and check out recordings of recent LTR conversations in the podcast section.


Bonus free content:


Premium content


Other articles:


Announcements

LTR monthly webinar series: Tips for software risk management

A quick reminder to join me in this month’s webinar, where I will review challenges and a few practical tips for software risk management.

If you are a paid subscriber, you will receive an email with a link to register for this month’s webinar on June 25, 2024 at 11:00 AM EST. You don’t need to pay extra.

If not, you can upgrade your subscription, or pay a one time fee of only $25 to attend this webinar. Click the link below to make a payment and secure your spot. Once you complete the payment, you will receive the registration link by email.

Register now to attend (Only $25)


LTR weekly conversation on LinkedIn: Open discussion

Join me next Friday, June 21, 2024 at 11:00 AM EST, for another Let’s Talk Risk! conversation on LinkedIn. This will be an open discussion to learn from each other some of the challenges and best practices in risk management.

Join the Conversation


Weekly Knowledge Challenge

I hope you enjoyed the knowledge challenge question last week. Here is the correct answer:

The correct answer to the question, “Which of the following is/are regulated by the FDA as a medical device?” is All of the above.

Here is this weeks’ knowledge challenge #37

Loading...

1-Question Feedback Survey

Loading...


Want to share feedback? Send a message to me!


If you are finding value in LTR, please give us a shout out and show your love🙏

Share your experience!

0 Comments